Clinical Trial Update: Samsca Post-marketing General Drug Use-results Survey in Patients with Hyponatremia in SIADH

View source ↗

Summary

This clinical trial update discusses a post-marketing general drug use-results survey evaluating tolvaptan (Samsca) for hyponatremia associated with SIADH.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hyponatremia
• Syndrome of Inappropriate Antidiuretic Hormone Secretion

Drugs mentioned

• Samsca (tolvaptan)

Snippet

Sponsor: Otsuka Pharmaceutical Co., Ltd. | Conditions: Antidiuretic Hormone, Inappropriate Secretion | Status: RECRUITING